Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusion

Ophthalmic Research

Volumn 45, Issue 4, 2011, Pages 204-209

  Rehak, Jiri ^a,d   Dusek, Ladislav ^b   Chrapek, Oldrich ^a   Fric, Evzen ^a   Rehak, Matus ^c  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d NONE   (Czech Republic)

Author keywords

Branch retinal vein occlusion, prognosis; Visual acuity

Indexed keywords

ASCORBIC ACID; PENTOXIFYLLINE; SALICYLIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; SEX DIFFERENCE; VISUAL ACUITY; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROGNOSIS; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; VISUAL ACUITY;

EID: 78149434390     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321701     Document Type: Article

References (28)

1. Gutman FA, Zegarra H, Zakov ZN: The natural course of temporal retinal vein occlusion. Trans Am Acad Opthalmol Otolaryngol 1974; 78: 178-192.
2. Magargal LE, Sanborn GE, Kimmel AS, Annesley WH: Temporal branch retinal vein obstruction: a review. Ophthalmic Surg 1986; 17: 240-246. (Pubitemid 16117096)
3. Michels RG, Gass JDM: Natural course of temporal retinal branch occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 166-177.
4. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and hemorrhage in branch vein occlusion. Arch Ophthalmol 1986; 104: 34-41.
5. Gutman FA: Macular edema in branch retinal vein occlusion: prognosis and management. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 488-493.
6. Schilling JS, Jones CA: Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular edema. Br J Ophthalmol 1984; 68: 196-198. (Pubitemid 15134727)
7. Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ: Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1241-1247.
8. Finkelstein D: Ischemic macular edema: recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992; 110: 1427-1434.
9. Scott IU, Van Veldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M, SCORE Study Investigator Group: SCORE study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009; 116: 504-512.
10. Ota M, Tsujikawa A, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Kotera Y, Yoshimura N: Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 2008; 28: 1502-1508.
11. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM: Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 1996; 103: 551-560. (Pubitemid 26114223)
12. Central Vein Occlusion Study Group: Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115: 486-491.
13. Rehak J, Rehak M: Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008; 33: 111-131. (Pubitemid 351302200)
14. Wetzig PC: The treatment of acute branch vein occlusion by photocoagulation. Am J Ophthalmol 1979; 87: 65-73. (Pubitemid 9098528)
15. Jalkh AE, Avila PM, Zakka KA, Trempe CL, Schepens CS: Chronic macular edema in retinal branch vein occlusion: role of laser photocoagulation. Ann Ophthalmol 1984; 16: 526-533. (Pubitemid 14092165)
16. Lang GE, Händel A: Ergebnisse der Laserkoagulation retinaler Venenastverschlüsse. Klin Monatsbl Augenheilkd 1993; 203: 180-188.
17. Eng J: ROC analysis: web-based calculator for ROC curves. Baltimore, Johns Hopkins University (updated May 17, 2006). http:// www.jrocfit.org .
18. SPSS for Windows, release 12.0.1. Chicago, SPSS Inc, 2003.
19. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK: Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-261.
20. Rehak M, Hollborn M, Iandiev I, Pannicke T, Karl A, Wurm A, Kohen L, Reichenbach A, Wiedemann P, Bringmann A: Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci 2009; 50: 2359-2367.
21. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol 1984; 98: 271-282.
22. Morse PH: Prospective rationale for and results of argon laser treatment of patients with branch retinal vein occlusion. Ann Ophthalmol 1985; 17: 565-571. (Pubitemid 15227910)
23. Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG: Preoperative visual acuity as a prognostic indicator for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2006; 37: 462-467. (Pubitemid 44902464)
24. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM: A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994; 118: 421-429. (Pubitemid 24307208)
25. Roseman RL, Olk RJ: Krypton red laser photocoagulation for branch retinal vein occlusion. Ophthalmology 1987; 94: 1120-1125. (Pubitemid 17151682)
26. Esrick E, Subramanian ML, Heier JS, Devaiah AK, Topping TM, Frederick AR, Morley MG: Multiple laser treatments for macular edema attributable to branch retinal vein occlusion. Am J Ophtalmol 2005; 139: 653-657.
27. Kondo M, Kondo N, Ito Y, et al: Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis. Retina 2009; 29: 1242-1248.
28. Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH, Retinal Vein Occlusion Study Group: Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, submitted.